SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 02/11/2022 | 3. Issuer Name and Ticker or Trading Symbol PAR TECHNOLOGY CORP [ PAR ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 7,011(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (2) | 07/29/2026 | Common Stock | 20,000 | 5.12 | D | |
Employee Stock Option (right to buy) | (3) | 08/13/2028 | Common Stock | 3,188 | 22.18 | D | |
Employee Stock Option (right to buy) | (4) | 08/09/2029 | Common Stock | 5,382 | 24.87 | D | |
Employee Stock Option (right to buy) | (5) | 08/11/2030 | Common Stock | 960 | 35.17 | D |
Explanation of Responses: |
1. Includes (1) a grant of 3,740 restricted stock units that vest in one-third increments on March 31, 2022, March 31, 2023 and March 31, 2024; and (2) a grant of 1,944 restricted stock units, with 50% of the restricted stock units vesting in one-third increments on March 31, 2022, March 31, 2023 and March 31, 2024 and the remaining 50% of the restricted stock units vesting in one-third increments on March 31,2022, March 31, 2023 and March 31, 2024 in a range from 0% to 160% based on the achievement of certain performance targets. |
2. Option vested in equal installments on July 29, 2017, July 29, 2018 and July 29, 2019. |
3. Option vested in equal installments on August 13, 2019, August 13, 2020 and August 13, 2021. |
4. Option vests in equal installments on August 9, 2020, August 9, 2021 and August 9, 2022. |
5. Option vests in equal installments on August 11, 2021, August 11, 2022 and August 11, 2023. |
Remarks: |
/s/ Cathy A. King | 02/18/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |